Lazard Asset Management’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.84M Sell
29,928
-15,448
-34% -$4.59M 0.01% 440
2025
Q4
$12.4M Sell
45,376
-47,408
-51% -$12.9M 0.02% 384
2025
Q3
$25.1M Buy
92,784
+7,878
+9% +$2.14M 0.03% 276
2025
Q2
$23.4M Buy
84,906
+33,910
+66% +$9.22M 0.03% 363
2025
Q1
$13.5M Buy
50,996
+26,897
+112% +$6.63M 0.02% 426
2024
Q4
$5.59M Sell
24,099
-13,070
-35% -$3.01M 0.01% 613
2024
Q3
$8.2M Buy
37,169
+18,780
+102% +$3.89M 0.01% 504
2024
Q2
$3.61M Buy
18,389
+10,079
+121% +$2.08M ﹤0.01% 752
2024
Q1
$1.79M Sell
8,310
-6,472
-44% -$1.36M ﹤0.01% 844
2023
Q4
$3.11M Sell
14,782
-3,213
-18% -$686K ﹤0.01% 779
2023
Q3
$3.6M Sell
17,995
-16,635
-48% -$3.31M ﹤0.01% 761
2023
Q2
$6.42M Buy
34,630
+3,470
+11% +$641K 0.01% 656
2023
Q1
$5.97M Sell
31,160
-3,827
-11% -$692K 0.01% 689
2022
Q4
$5.88M Buy
34,987
+26,822
+328% +$4.66M 0.01% 683
2022
Q3
$1.45M Buy
8,165
+1,153
+16% +$228K ﹤0.01% 936
2022
Q2
$1.43M Buy
7,012
+5,735
+449% +$1.22M ﹤0.01% 956
2022
Q1
$303K Buy
1,277
+21
+2% +$4.93K ﹤0.01% 1191
2021
Q4
$285K Sell
1,256
-114
-8% -$25.1K ﹤0.01% 1203
2021
Q3
$264K Buy
1,370
+133
+11% +$26.9K ﹤0.01% 1258
2021
Q2
$262K Sell
1,237
-2,882
-70% -$608K ﹤0.01% 1174
2021
Q1
$840K Sell
4,119
-8,940
-68% -$1.76M ﹤0.01% 913
2020
Q4
$2.38M Buy
13,059
+9,524
+269% +$1.62M ﹤0.01% 765
2020
Q3
$590K Buy
3,535
+1,794
+103% +$302K ﹤0.01% 854
2020
Q2
$282K Buy
1,741
+1,641
+1,641% +$294K ﹤0.01% 890
2020
Q1
$17K Hold
100
﹤0.01% 1463
2019
Q4
$20K Hold
100
﹤0.01% 1227
2019
Q3
$21K Hold
100
﹤0.01% 1066
2019
Q2
$19K Sell
100
-20,085
-100% -$3.7M ﹤0.01% 1140
2019
Q1
$3.32M Buy
+20,185
New +$3.57M 0.01% 659
2018
Q4
Sell
-1
Closed 1033
2018
Q3
$0 Sell
1
-734
-100% -$124K ﹤0.01% 1055
2018
Q2
$120K Buy
+735
New +$120K ﹤0.01% 894
2018
Q1
Sell
-8,464
Closed -$1.24M 1051
2017
Q4
$1.24M Buy
+8,464
New +$1.21M ﹤0.01% 677
2015
Q4
Sell
-88
Closed -$8K 1108
2015
Q3
$8K Buy
+88
New +$8.37K ﹤0.01% 1013
2014
Q3
Sell
-4,288
Closed -$303K 1044
2014
Q2
$303K Buy
4,288
+1,750
+69% +$123K ﹤0.01% 822
2014
Q1
$187K Buy
2,538
+22
+0.9% +$1.66K ﹤0.01% 827
2013
Q4
$197K Buy
+2,516
New +$197K ﹤0.01% 828

Other funds holding CME

Lazard Asset Management's CME Position: Q1 2026 in Review

Lazard Asset Management reduced its CME Group (CME) stake by 34% in Q1 2026, selling an estimated $4.59M and leaving 29,928 shares worth $8.84M. The position accounts for 0.01% of the portfolio, ranked #440.

Lazard Asset Management first reported a position in CME in Q4 2013 and has held it in 36 quarters since. The position peaked at $25.1M in Q3 2025. 1,790 funds tracked by Wall St. Rank hold CME as of Q1 2026.

  • Lazard Asset Management held 29,928 shares of CME Group worth $8.84M as of Q1 2026.
  • Lazard Asset Management sold 15,448 CME Group shares in Q1 2026, an estimated $4.59M.
  • CME Group made up 0.01% of Lazard Asset Management's portfolio in Q1 2026, its #440 holding.
  • Lazard Asset Management first reported a position in CME Group in Q4 2013 and has held it in 36 quarters since.
  • Lazard Asset Management's CME Group position peaked at $25.1M in Q3 2025.
  • 1,790 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on Lazard Asset Management's 13F filing for Q1 2026, filed 15 May 2026.